Grandes estudios en enfermedad coronaria: COURAGE, FAME y SYNTAX Dr. Conrad Simpfendorfer Heart & Vascular Institute Cleveland Clinic Estados Unidos
During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.
Discover the presentations of the prestigious interventionists that made part of this 13th edition...
For the thirteenth consecutive year, we will be hosting an educational excellence course for interventionalists in training from Latin America: the ProEducar-SOLACI Fellows Course.
This one-day...
During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.
Discover the presentations of the prestigious interventionists that made...
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....
